Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Two individuals with AEBP1-related classical-like EDS: Further clinical characterisation and description of novel AEBP1 variants. | Front Genet | 2023 | 37144134 | PubTator, text mining | PubMed |
| Combination of anti-C1qA08 and anti-mCRP a.a.35-47 antibodies is associated with renal prognosis of patients with lupus nephritis. | Front Immunol | 2023 | 37138875 | PubTator, text mining | PubMed |
| Rituximab in the Treatment of Acquired Angioedema Secondary to Marginal Zone Lymphoma of the Spleen. | Cureus | 2023 | 37123708 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system. | Front Immunol | 2023 | 37122721 | PubTator, text mining | PubMed |
| Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway. | J Med Chem | 2023 | 37120845 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation. | Nat Commun | 2023 | 37120617 | PubTator, text mining | PubMed |
| An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy. | J Peripher Nerv Syst | 2023 | 37119056 | PubTator, text mining | PubMed |
| Integrative analyses of biomarkers and pathways for diabetic nephropathy. | Front Genet | 2023 | 37113991 | PubTator, text mining | PubMed |
| New Biosensor for Determination of Neuropilin-1 with Detection by Surface Plasmon Resonance Imaging. | Sensors (Basel) | 2023 | 37112459 | PubTator, text mining | PubMed |
| Immune-Mediated Neuropathies: Pathophysiology and Management. | Int J Mol Sci | 2023 | 37108447 | PubTator, text mining | PubMed |
| Retinal Aging Transcriptome and Cellular Landscape in Association With the Progression of Age-Related Macular Degeneration. | Invest Ophthalmol Vis Sci | 2023 | 37099020 | PubTator, text mining | PubMed |
| Complement Activation by Adeno-Associated Virus-Neutralizing Antibody Complexes. | Hum Gene Ther | 2023 | 37082966 | PubTator, text mining | PubMed |
| A Rare Case Report of Periorbital Pseudolymphoma. | Cureus | 2023 | 37073202 | PubTator, text mining | PubMed |
| Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis. | PeerJ | 2023 | 37065697 | PubTator, text mining | PubMed |
| Platelets promote CRC by activating the C5a/C5aR1 axis via PSGL-1/JNK/STAT1 signaling in tumor-associated macrophages. | Theranostics | 2023 | 37064877 | PubTator, text mining | PubMed |
| Characteristics and management of thrombotic microangiopathy in kidney transplantation. | Korean J Transplant | 2023 | 37064766 | PubTator, text mining | PubMed |
| Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists. | Bone Marrow Transplant | 2023 | 37059738 | PubTator, text mining | PubMed |
| Detection of Alzheimer's disease onset using MRI and PET neuroimaging: longitudinal data analysis and machine learning. | Neural Regen Res | 2023 | 37056120 | PubTator, text mining | PubMed |
| Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. | J Clin Invest | 2023 | 37053016 | PubTator, text mining | PubMed |
| EBD: an eye biomarker database. | Bioinformatics | 2023 | 37052519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=19